• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Neoadjuvant therapy of locally advanced squamous cell carcinoma of the esophagus : Radiochemotherapy vs. doublet or triplet chemotherapy alone].

作者信息

Drabke Sophia, Kaufmann Justus, Schmidberger Heinz

机构信息

Klinik und Poliklinik für Radioonkologie und Strahlentherapie, Universitätsmedizin Mainz, Langenbeckstraße 1, 55131, Mainz, Deutschland.

Arbeitsgruppe junge DEGRO der Deutschen Gesellschaft für Radioonkologie e. V. (DEGRO), Berlin, Deutschland.

出版信息

Strahlenther Onkol. 2024 Dec;200(12):1100-1102. doi: 10.1007/s00066-024-02310-x. Epub 2024 Oct 14.

DOI:10.1007/s00066-024-02310-x
PMID:39402378
Abstract
摘要

相似文献

1
[Neoadjuvant therapy of locally advanced squamous cell carcinoma of the esophagus : Radiochemotherapy vs. doublet or triplet chemotherapy alone].[局部晚期食管鳞状细胞癌的新辅助治疗：放化疗与单纯双联或三联化疗对比]
Strahlenther Onkol. 2024 Dec;200(12):1100-1102. doi: 10.1007/s00066-024-02310-x. Epub 2024 Oct 14.
2
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.双药化疗、三药化疗或双药化疗联合放疗作为局部晚期食管癌的新辅助治疗（JCOG1109 NExT）：一项随机、对照、开放标签、III 期临床试验。
Lancet. 2024 Jul 6;404(10447):55-66. doi: 10.1016/S0140-6736(24)00745-1. Epub 2024 Jun 11.
3
Induction treatment with FOLFIRINOX or oxaliplatin-based doublet followed by long-course chemoradiotherapy and surgery in locally advanced rectal cancer. A systematic review and pooled analysis from phase II and III trials.局部晚期直肠癌的 FOLFIRINOX 或奥沙利铂为基础的双联方案诱导治疗，随后进行长程放化疗和手术：来自 II 期和 III 期试验的系统评价和汇总分析。
Cancer Treat Rev. 2024 Nov;130:102829. doi: 10.1016/j.ctrv.2024.102829. Epub 2024 Sep 16.
4
Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.新辅助放化疗对局部晚期食管鳞状细胞癌病理分期及预后的影响。
Dis Esophagus. 2009;22(6):477-81. doi: 10.1111/j.1442-2050.2008.00910.x.
5
Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs . chemotherapy alone in HER2(-) locally advanced gastric cancer: A propensity score-matched cohort study.免疫检查点抑制剂联合化疗与单纯化疗用于HER2（-）局部晚期胃癌的新辅助治疗：一项倾向评分匹配队列研究
Chin Med J (Engl). 2025 Feb 20;138(4):459-471. doi: 10.1097/CM9.0000000000003028. Epub 2024 Feb 29.
6
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.德国食管癌鳞状细胞癌和腺癌诊断与治疗的最新指南。
United European Gastroenterol J. 2024 Apr;12(3):399-411. doi: 10.1002/ueg2.12523. Epub 2024 Jan 29.
7
A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.局部晚期胃癌新辅助化疗的回顾性研究
Cancer Manag Res. 2020 Sep 15;12:8491-8496. doi: 10.2147/CMAR.S267330. eCollection 2020.
8
Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis.三药联合与两药联合新辅助化疗方案治疗局部进展期胃癌的倾向评分匹配分析。
BMC Cancer. 2021 Dec 13;21(1):1328. doi: 10.1186/s12885-021-09093-9.
9
[Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].[新辅助放化疗还是化疗用于局部晚期食管癌？]
Chirurg. 2020 May;91(5):379-383. doi: 10.1007/s00104-020-01150-6.
10
Prospective, open, multicentre Phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and cisplatin for esophageal carcinoma.前瞻性、开放、多中心 I/II 期试验，评估多西他赛和顺铂新辅助放化疗治疗食管癌的安全性和疗效。
Jpn J Clin Oncol. 2015 Feb;45(2):169-75. doi: 10.1093/jjco/hyu181. Epub 2014 Nov 21.

本文引用的文献

1
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial.双药化疗、三药化疗或双药化疗联合放疗作为局部晚期食管癌的新辅助治疗（JCOG1109 NExT）：一项随机、对照、开放标签、III 期临床试验。
Lancet. 2024 Jul 6;404(10447):55-66. doi: 10.1016/S0140-6736(24)00745-1. Epub 2024 Jun 11.
2
Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study.新辅助卡铂/紫杉醇与5-氟尿嘧啶/顺铂联合放疗治疗局部晚期食管鳞状细胞癌的多中心对比研究
Cancers (Basel). 2022 May 25;14(11):2610. doi: 10.3390/cancers14112610.
3
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.纳武利尤单抗辅助治疗食管或胃食管结合部癌。
N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125.
4
Multimodality treatment of locally advanced squamous cell carcinoma of the oesophagus: A comprehensive review and network meta-analysis.局部晚期食管癌的多模态治疗：一项全面综述与网状Meta分析
Crit Rev Oncol Hematol. 2017 Jun;114:24-32. doi: 10.1016/j.critrevonc.2017.03.024. Epub 2017 Mar 23.
5
Preoperative chemoradiotherapy for esophageal or junctional cancer.术前放化疗治疗食管或食管胃交界癌。
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.